ConductScience.org, home

Paper511351

Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim.

Ortengren B and 2 others. Infection, 1979. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim. Papers, record 511351. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/511351

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim.
PubMed
Journal
Infection
PubMed
Year
1979
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
0.96
iCite
Revised in PubMed
2019-08-27
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ortengren BB
2Magni LL
3Bergan TT

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SulfonamidesMajor topic
TrimethoprimMajor topic
Urinary Tract InfectionsMajor topic
Drug Combinations
Female
Half-Life
Humans
Kinetics
Sulfadiazine
Sulfamethoxazole

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14893676Progress in sulfonamide research.Prog Drug Res1968https://conductscience.org/library/papers/4893676PubMed
24901344Single-blind comparative trial of trimethoprim-sulphamethoxazole and ampicillin in the treatment of exacerbations of chronic bronchitis.Br Med J1969https://conductscience.org/library/papers/4901344PubMed
34669555Kidney transport in man of sulfamethoxazole and trimethoprim.Chemotherapy1972https://conductscience.org/library/papers/4669555PubMed
44148900Influence of sulfonamide antagonists on the synergism of sulfamethoxazole-trimethoprim in Escherichia coli.Zentralbl Bakteriol Orig A1973https://conductscience.org/library/papers/4148900PubMed
54595634Pharmacokinetic studies with trimethoprim and different doses of sulfadiazine in healthy human subjects.Chemotherapy1973https://conductscience.org/library/papers/4595634PubMed
65009465Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids.Chemotherapy1972https://conductscience.org/library/papers/5009465PubMed
74463825Pharmacokinetics of the antibacterial combination sulfamethoxazole plus trimethoprim in patients with normal or impaired kidney function.Antibiot Chemother (1971)1974https://conductscience.org/library/papers/4463825PubMed
84908562[Comparative bacteriological investigations with the combination trimethoprim/sulfamethoxazole in vitro and in vivo].Chemotherapy1969https://conductscience.org/library/papers/4908562PubMed
95057618Investigation of sulfonamide crystalluria in man.Scand J Urol Nephrol1972https://conductscience.org/library/papers/5057618PubMed
105325631The role of the therapeutic regimen in dosage design. II.Chemotherapy1965https://conductscience.org/library/papers/5325631PubMed
11374276Antibacterial activity of co-trimazine in vitro and in vivo.Infection1979https://conductscience.org/library/papers/374276PubMed
124974510Trimethoprim in the treatment of urinary infections in hospital.Br Med J1969https://conductscience.org/library/papers/4974510PubMed
134571975
The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
Chemotherapy1973https://conductscience.org/library/papers/4571975PubMed
154412673Cross-over study of penicillin pharmacokinetics after intravenous infusions.Chemotherapy1974https://conductscience.org/library/papers/4412673PubMed
165514974Pharmacokinetics of sulfamethoxazole plus trimethoprim in man and their distribution in the rat.Chemotherapy1970https://conductscience.org/library/papers/5514974PubMed
174958410The binding of antibiotics to serum proteins.Br J Pharmacol Chemother1965https://conductscience.org/library/papers/4958410PubMed
184640694Human pharmacokinetics of a sulfamethoxazole-trimethoprim combination.Acta Med Scand1972https://conductscience.org/library/papers/4640694PubMed
195419724Effective plasma and urine concentration of some sulfonamides and sulfonamide combinations.Ann Med Exp Biol Fenn1970https://conductscience.org/library/papers/5419724PubMed
201159621Elimination kinetics of sulfadiazine in patients with normal and impaired renal function.J Pharmacokinet Biopharm1975https://conductscience.org/library/papers/1159621PubMed

Download CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
38172623The Vibrio cholerae CBASS phage defence system modulates resistance and killing by antifolate antibiotics.Nat Microbiol2024https://conductscience.org/library/papers/38172623PubMed
33182761A Physiologically-Based Pharmacokinetic Model of Trimethoprim for MATE1, OCT1, OCT2, and CYP2C8 Drug-Drug-Gene Interaction Predictions.Pharmaceutics2020https://conductscience.org/library/papers/33182761PubMed
6759092Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.Drugs1982https://conductscience.org/library/papers/6759092PubMed
3536256Clinical pharmacokinetics of co-trimazine.Clin Pharmacokinet1986https://conductscience.org/library/papers/3536256PubMed
3052984Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.Clin Pharmacokinet1988https://conductscience.org/library/papers/3052984PubMed
511355Trimethoprim/sulphonamide: concluding remarks.Infection1979https://conductscience.org/library/papers/511355PubMed
511352Pharmacokinetics of sulphadiazine, sulphamethoxazole and trimethoprim in patients with varying renal function.Infection1979https://conductscience.org/library/papers/511352PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/511351

GET https://conductscience.org/api/papers/v1/511351/authors